Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Leading Change in Academic Pharmacy: Report of the 2018-2019 AACP Academic Affairs Committee.

Gregory DF, Boje KM, Carter RA, Daugherty KK, Hagemeier NE, Munger MA, Umland EM, Wagner JL.

Am J Pharm Educ. 2019 Dec;83(10):7661. doi: 10.5688/ajpe7661.

2.

Consideration of Aggressive and Strategic Approaches to Address Declining Enrollment in US Pharmacy Schools.

Pavuluri N, Aparasu RR, Boje KMK, Danielson J, El-Ibiary SY, Iyer AKV, Ochs LA, Robinson JD, Shah S, Williams CC, Moore TM, Wargo KA.

Am J Pharm Educ. 2019 Aug;83(6):6959. doi: 10.5688/ajpe6959. Review.

3.

In vivo measurement of blood-brain barrier permeability.

Boje KM.

Curr Protoc Neurosci. 2001 Aug;Chapter 7:Unit 7.19. doi: 10.1002/0471142301.ns0719s15.

PMID:
18428529
4.
5.

Pharmacokinetics and pharmacodynamics of gamma-hydroxybutyric acid during tolerance in rats: effects on extracellular dopamine.

Raybon JJ, Boje KM.

J Pharmacol Exp Ther. 2007 Mar;320(3):1252-60. Epub 2006 Nov 30.

PMID:
17138862
7.
8.
9.

GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood-brain barrier.

Bhattacharya I, Boje KM.

J Pharmacol Exp Ther. 2004 Oct;311(1):92-8. Epub 2004 Jun 1.

PMID:
15173314
10.

Nitric oxide neurotoxicity in neurodegenerative diseases.

Boje KM.

Front Biosci. 2004 Jan 1;9:763-76. Review.

PMID:
14766406
11.
12.

In vivo measurement of blood-brain barrier permeability.

Boje KM.

Curr Protoc Pharmacol. 2002 Aug;Chapter 7:Unit 7.4. doi: 10.1002/0471141755.ph0704s17.

PMID:
22294082
13.
14.
15.

Blood-brain barrier transport studies of organic guanidino cations using an in situ brain perfusion technique.

Mahar Doan KM, Lakhman SS, Boje KM.

Brain Res. 2000 Sep 8;876(1-2):141-7.

PMID:
10973602
16.

Nitric oxide redox species exert differential permeability effects on the blood-brain barrier.

Boje KM, Lakhman SS.

J Pharmacol Exp Ther. 2000 May;293(2):545-50.

PMID:
10773027
17.
18.

Quantification of iNOS mRNA with reverse transcription polymerase chain reaction directly from cell lysates.

Han B, DuBois DC, Boje KM, Free SJ, Almon RR.

Nitric Oxide. 1999 Aug;3(4):281-91.

PMID:
10444367
19.

Improved high-performance liquid chromatographic assay for nimesulide.

Jaworowicz DJ Jr, Filipowski MT, Boje KM.

J Chromatogr B Biomed Sci Appl. 1999 Feb 19;723(1-2):293-9.

PMID:
10080658
20.

Nitric oxide and prostaglandin E2 formation parallels blood-brain barrier disruption in an experimental rat model of bacterial meningitis.

Jaworowicz DJ Jr, Korytko PJ, Singh Lakhman S, Boje KM.

Brain Res Bull. 1998 Aug;46(6):541-6.

PMID:
9744292
22.

Chronic administration of NMDA glycine partial agonists induces tolerance in the Porsolt swim test.

Lopes T, Neubauer P, Boje KM.

Pharmacol Biochem Behav. 1997 Dec;58(4):1059-64.

PMID:
9408214
24.

Pharmacological characterization of nitric oxide production in a rat model of meningitis.

Korytko PJ, Boje KM.

Neuropharmacology. 1996 Feb;35(2):231-7.

PMID:
8734493
25.

Cerebrovascular permeability changes during experimental meningitis in the rat.

Boje KM.

J Pharmacol Exp Ther. 1995 Sep;274(3):1199-203.

PMID:
7562488
28.

Desensitization of the NMDA receptor complex by glycinergic ligands in cerebellar granule cell cultures.

Boje KM, Wong G, Skolnick P.

Brain Res. 1993 Feb 19;603(2):207-14.

PMID:
8096423
29.
30.

High-performance liquid chromatographic assay for 1-aminocyclopropanecarboxylic acid from plasma and brain.

Miller R, La Grone J, Skolnick P, Boje KM.

J Chromatogr. 1992 Jul 1;578(1):103-8.

PMID:
1400774
31.

Strychnine-insensitive glycine receptors in embryonic chick retina: characteristics and modulation of NMDA neurotoxicity.

Boje KM, Skolnick P, Raber J, Fletcher RT, Chader G.

Neurochem Int. 1992 Jun;20(4):473-86.

PMID:
1339019
32.
33.

Ontogeny of glycine-enhanced [3H]MK-801 binding to N-methyl-D-aspartate receptor-coupled ion channels.

Boje KM, Skolnick P.

Brain Res Dev Brain Res. 1992 Jan 17;65(1):51-6.

PMID:
1372541
34.
35.

Pharmacokinetic interaction between ethanol and nitrendipine in the rat: role of hypothermia as a contributing mechanism.

Boje KM, Fung HL.

Drug Metab Dispos. 1990 Jan-Feb;18(1):127-9. No abstract available.

PMID:
1970772
36.

Characterization of the pharmacokinetic interaction between nifedipine and ethanol in the rat.

Boje KM, Fung HL.

J Pharmacol Exp Ther. 1989 May;249(2):567-71.

PMID:
2724140
37.

Complexation of nifedipine with substituted phenolic ligands.

Boje KM, Sak M, Fung HL.

Pharm Res. 1988 Oct;5(10):655-9.

PMID:
3244619
38.

Haemodynamic effects of combined oral nifedipine and sublingual nitroglycerin in patients with chronic stable angina.

Boje KM, Fung HL, Yoshitomi K, Parker JO.

Eur J Clin Pharmacol. 1987;33(4):349-54.

PMID:
3127220
39.

Oral ethanol ingestion altered nifedipine pharmacokinetics in the rat: a preliminary study.

Boje KM, Dolce JA, Fung HL.

Res Commun Chem Pathol Pharmacol. 1984 Nov;46(2):219-26.

PMID:
6515116

Supplemental Content

Support Center